Our clinical trials network
The North American Clinical Trials Network (NACTN) works to bring promising therapies out of the laboratory and into clinical trials, in a manner that provides strong evidence of effectiveness and safety.
>About NACTN
Learn how NACTN works to evaluate the safety and effectiveness of potential treatments for spinal cord injury.
>NACTN sites
There are 10 NACTN clinical centers in North America with additional sites for data management and pharmacology.
>NACTN SCI Registry
The NACTN SCI Registry tracks acute care and follow-up data on patients following a spinal cord injury.
>What are clinical trials?
Common questions, and a look at some of the current clinical trials that are exploring new frontiers in the field.
>Interested in joining a study?
It is important for patients to educate themselves and ask questions before volunteering to join a clinical trial.
>NACTN publications
Review highlights from the Journal of Neurosurgery Focus Issue on spinal cord injury, September 2012, v17.
>Riluzole in Spinal Cord Injury Study (RISCIS)
RISCIS is a study supported by NACTN and AOSpine North America to evaluate the safety of riluzole in treating SCI.